CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma

CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma

Show other versions (1)

Bibliographic Details
Main Authors:	Guang Wang, Juan Fu, Mulin Liu, Qin Zheng
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793908/?tool=EBI

Similar Items

CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.
by: Guang Wang, et al.
Published: (2024-01-01)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
by: Jiacheng Huang, et al.
Published: (2021-08-01)

Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment
by: Qingquan Zeng, et al.
Published: (2020-02-01)

The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
by: Jan Korbecki, et al.
Published: (2021-01-01)

Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment
by: Weina Kong, et al.
Published: (2021-07-01)

CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
by: Xuezhi Zhou, et al.
Published: (2021-03-01)

Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines
by: Xiaoqi Sun, et al.
Published: (2021-07-01)

Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico Approach
by: Tesfaye Wolde, et al.
Published: (2024-02-01)

The Role of CXC Chemokines in Cancer Progression
by: Tiantian Wu, et al.
Published: (2022-12-01)

The Role of CXC Chemokines in Cardiovascular Diseases
by: Xiyi Lu, et al.
Published: (2022-05-01)

FEATURES OF LOCAL mRNA SYNTHESIS FOR SOME CC- AND CXC-CHEMOKINES AND THEIR RECEPTORS IN ENDOMETRIAL HYPERPLASIA
by: N. V. Kipich, et al.
Published: (2014-07-01)

The role of CXC cytokines as biomarkers and potential targets in hepatocellular carcinoma
by: Yonghui Wang, et al.
Published: (2020-01-01)

Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
by: Li-Peng Pei, et al.
Published: (2022-06-01)

Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma
by: Li D, et al.
Published: (2021-09-01)

Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma
by: Wang K, et al.
Published: (2022-02-01)

Regulation of Expression of CXC Chemokines in Cultured Hepatocytes
by: GhH Hassanshahiraviz, et al.
Published: (2005-10-01)

Regulation of Expression of CXC Chemokines in Cultured Hepatocytes
by: GhH Hassanshahiraviz, et al.
Published: (2005-03-01)

RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma
by: Jianming Tang, et al.
Published: (2022-08-01)

Exploring Prognosis-Associated Biomarkers of Estrogen-Independent Uterine Corpus Endometrial Carcinoma by Bioinformatics Analysis
by: Ye Y, et al.
Published: (2021-11-01)

Metabolism-associated molecular classification of uterine corpus endometrial carcinoma
by: Munan Zhao, et al.
Published: (2023-01-01)

Biophysical characterization of the CXC chemokine receptor 2 ligands
by: Patrick Martin, et al.
Published: (2024-01-01)

Pan-cancer analysis identifies LIFR as a prognostic and immunological biomarker for uterine corpus endometrial carcinoma
by: Fang Zhang, et al.
Published: (2023-02-01)

CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives
by: Xinxin Huang, et al.
Published: (2022-02-01)

Mechanism investigation and experiment validation of capsaicin on uterine corpus endometrial carcinoma
by: Zhiheng Lin, et al.
Published: (2022-09-01)

CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets
by: Liu F, et al.
Published: (2021-02-01)

The therapeutic potential of CXC chemokine blockade in acute inflammation in the brain.
by: Anthony, D, et al.
Published: (1999)

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis.
by: Mehrnaz Gharaee-Kermani, et al.
Published: (2012-01-01)

The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis.
by: Sallouha Aidoudi, et al.
Published: (2008-01-01)

CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer
by: Naoya Nagaya, et al.
Published: (2020-10-01)

ELR+ CXC chemokine expression in benign and malignant colorectal conditions
by: Brittner Brigitte, et al.
Published: (2008-06-01)

Tumor mutation burden in connection with immune-related survival in uterine corpus endometrial carcinoma
by: Ling Zhao, et al.
Published: (2021-01-01)

Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
by: Cankun Zhou, et al.
Published: (2020-11-01)

Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma
by: Yongchao Li, et al.
Published: (2021-01-01)

KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma
by: Kang He, et al.
Published: (2023-01-01)

UBE2C serves as a prognosis biomarker of uterine corpus endometrial carcinoma via promoting tumor migration and invasion
by: Sijia Ma, et al.
Published: (2023-10-01)

Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma
by: Qi Zhang, et al.
Published: (2024-02-01)

Catecholamines Promote Ovarian Cancer Progression through Secretion of CXC-Chemokines
by: Hyun Jung Kim, et al.
Published: (2023-09-01)

Structural basis of CXC chemokine receptor 1 ligand binding and activation
by: Naito Ishimoto, et al.
Published: (2023-07-01)

Function of chemokine (CXC motif) ligand 12 in periodontal ligament fibroblasts.
by: Yuichi Yashiro, et al.
Published: (2014-01-01)

CXC chemokines function as a rheostat for hepatocyte proliferation and liver regeneration.
by: Gregory C Wilson, et al.
Published: (2015-01-01)